More about

Lymphoma

News
August 11, 2022
3 min read
Save

Third dose of COVID-19 vaccine effective for immunocompromised patients with blood cancers

Third dose of COVID-19 vaccine effective for immunocompromised patients with blood cancers

A third dose of the mRNA-1273 vaccine for COVID-19 significantly improved SARS-CoV-2 antibody concentrations among patients with hematologic malignancies who previously received two doses, results of a prospective study showed.

News
July 26, 2022
9 min read
Save

CAR-T pioneer a ‘galvanizing’ force in research community

CAR-T pioneer a ‘galvanizing’ force in research community

Perhaps no one has been better prepared to become a leader in the field of cancer cellular immunotherapy than Marcela V. Maus, MD, PhD.

News
July 25, 2022
1 min read
Save

Cardiovascular disease, not cancer, top cause of death among Hodgkin lymphoma survivors

Patients with early-stage classic Hodgkin lymphoma and other neoplasms exhibited higher risk for cardiovascular disease-associated mortality compared with cancer-associated mortality later in life, according to study results.

News
July 21, 2022
2 min read
Save

Incidence of lymphoma subtype linked to breast implants rises rapidly in US

Incidence of lymphoma subtype linked to breast implants rises rapidly in US

Age-adjusted incidence of anaplastic large-cell lymphoma of the breast rapidly increased in the U.S. between 2000 and 2018, according to a research letter published in JAMA Oncology.

News
July 11, 2022
2 min read
Save

Patients with blood cancers show immune response to COVID-19 vaccine boosters

Patients with blood cancers show immune response to COVID-19 vaccine boosters

Less than half of patients with hematologic malignances exhibited seroconversion after receiving their initial COVID-19 vaccine, research published in Cancer showed.

News
July 08, 2022
3 min read
Save

CAR-T recipients require ‘fair amount’ of health care resources after treatment

CAR-T recipients require ‘fair amount’ of health care resources after treatment

Nearly 40% of patients who received chimeric antigen receptor T-cell therapy required hospitalization for disease- or treatment-related reasons in the year after infusion, results of a research letter in JAMA Oncology showed.

News
June 30, 2022
4 min read
Save

Death in hospice facility less common among rural vs. urban residents with blood cancer

Death in hospice facility less common among rural vs. urban residents with blood cancer

Patients with hematologic malignancies who resided in rural areas had a lower likelihood of death in a hospice facility but higher likelihood of dying in a nursing facility than their urban counterparts, according to study results.

News
June 27, 2022
2 min read
Save

FDA expands Breyanzi approval for relapsed or refractory large B-cell lymphoma

FDA expands Breyanzi approval for relapsed or refractory large B-cell lymphoma

The FDA approved lisocabtagene maraleucel for treatment of adults with relapsed or refractory large B-cell lymphoma after one prior therapy.

News
June 24, 2022
3 min read
Save

CAR-T demonstrates efficacy as second-line therapy for transplant-ineligible lymphoma

CAR-T demonstrates efficacy as second-line therapy for transplant-ineligible lymphoma

CHICAGO — Second-line therapy with lisocabtagene maraleucel induced initial complete remission among more than half of patients with relapsed or refractory transplant-ineligible large B-cell lymphoma, results from a phase 2 trial showed.

News
June 24, 2022
2 min read
Save

What is carcinoma?

What is carcinoma?

The most common type of cancer in humans is carcinoma.

View more